中国脑血管病杂志2025，Vol.22Issue(4)：277-284,8.DOI:10.3969/j.issn.1672-5921.2025.04.008
基于缺血性卒中和出血性卒中共有代谢物探讨卒中异病同治
Homotherapy for hetropathy of ischemic stroke and hemorrhagic stroke through common metabolites
陈绍静 1蒋萍 2沈淑洁 3俞捷 1高颖 2尚明英 3刘广学 3蔡少青 3徐风3
作者信息
- 1. 650500 昆明,云南中医药大学中药学院
- 2. 北京中医药大学东直门医院脑病二科
- 3. 北京大学药学院生药学研究室
- 折叠
摘要
Abstract
Ischemic stroke and hemorrhagic stroke have different pathogenic mechanisms,but share similarities in metabolic dysregulation,inflammatory responses and oxidative stress.This paper summarized 28 metabolic markers shared between ischemic stroke and hemorrhagic stroke with consistent trends through literature review.It also provided an overview of their involvement in abnormal energy metabolism,inflammatory responses,blood-brain barrier disruption,and neural damage in relation to stroke.The aim is to provide a scientific basis for future prognosis,curative efficacy evaluation and future homotherapy of ischemic stroke and hemorrhagic stroke,and provide insights for the development of new therapies and new drugs.关键词
卒中/生物标志物/代谢物/综述Key words
Stroke/Biomarkers/Metabolites/Review引用本文复制引用
陈绍静,蒋萍,沈淑洁,俞捷,高颖,尚明英,刘广学,蔡少青,徐风..基于缺血性卒中和出血性卒中共有代谢物探讨卒中异病同治[J].中国脑血管病杂志,2025,22(4):277-284,8.
